US29772L1089
US29772L1089
Eton Pharmaceuticals, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.58B EUR | 1.02B EUR | 675.24M EUR | 457.37M EUR |
Enterprise Value | 1.57B EUR | 1.03B EUR | 686.77M EUR | 462.44M EUR |
Valuation Multiples | ||||
Trailing P/E | 138.03x | 80.71x | -- | -- |
Forward P/E | 21.4x | -- | -- | -- |
Price to Sales | 14.94x | 9.7x | 7.77x | 7.3x |
Price to Book | 33.52x | 21.98x | 22.06x | 17.49x |
EV/Revenue | 14.84x | 9.72x | 7.9x | 7.38x |
EV/EBITDA | 62.25x | 49.22x | 110.73x | 174.05x |
Price to FCF (P/FCF) | 239.78x | -- | 1,566.68x | 56.46x |
EV/FCF | 238.15x | -- | 1,593.42x | 57.08x |
FCF Yield | 0.42% | -0.03% | 0.06% | 1.77% |